ArticleJTO clinical and research reports2022

A Real-World Analysis of Immune Checkpoint Inhibitor-Based Therapy After Osimertinib Treatment in Patients With

Kenji Morimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.